Advisor Resource Council

Position in RPRX — Royalty Pharma plc

CIK 1820879 DALLAS, TX

Position in RPRX

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$897,288

+$134,470 QoQ

Shares Held

16,003

+0.6% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.52%

of 13F equity value

Holder Rank

#342

of 641 holders

Holding Since

Mar 2025

5 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Advisor Resource Council holds $1,698,942 across 4 Biotechnology names. RPRX ranks #1 (52.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc This page	16,003	$897,288
2	LGND	Ligand Pharmaceuticals Inc	1,147	$362,555
3	ROIV	Roivant Sciences Ltd.	6,929	$245,217
4	AUPH	Aurinia Pharmaceuticals Inc.	11,425	$193,882

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$897,288	16,003	+0.6%	Shares	Sole	2026-07-28
2026-03-31	$762,818	15,902	+4.9%	Shares	Sole	2026-05-07
2025-12-31	$585,473	15,152	+109.9%	Shares	Sole	2026-02-10
2025-06-30	$260,028	7,217	-92.0%	Shares	Sole	2025-08-11
2025-03-31	$2,819,662	90,577	—	Shares	Sole	2025-04-22
No filing history on record for this holder in this stock.